Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Podcast Part I: John Sterling, Editor in Chief of Genetic Engineering and Biotechnology News (GEN)

John discusses the state of the industry and what he expects will be the top three issues highlighted at this year's BIO International Convention.  For more information on GEN, please visit http://www.genengnews.com/

BIO and BVGH on Global Health

BIO's President and CEO Jim Greenwood talks to BIO Ventures for Global Health (BVGH) CEO Don Joseph about global health and BVGH's new report on global health.

The Life Sciences Foundation

BIO President and CEO Jim Greenwood talks with Arnold Thackray, President and CEO of the Life Sciences Foundation, about how the life sciences will shape the course of the 21st century.

Andrew Emmett on PDUFA and the 2012 BIO International Convention

Andrew Emmett, Managing Director, Science & Regulatory Affairs, speaks about the important regulatory issues facing the industry, specifically PDUFA reauthorization, the FDA and regulation. Also, hear his programming highlights from the Achieving Regulatory Approval and Compliance Track at the upcoming 2012 BIO International Convention.

Therapeutic Discovery Project Defending America's Competitiveness in Biotechnology

Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.

Therapeutic Discovery Project Helps Scientists Working To Cure Cancer

BIO believes that the level of support provided by the TDP simply cannot meet the needs of the growing biotech field. As evidence of the project's popularity suggests, Congress should consider extending or expanding the project in order to support American innovation and speed the development of life-saving cures.

Therapeutic Discovery Project Is Working to Create & Protect American Jobs

The biotech industry is a thriving sector employing 1.3 million Americans in high quality, high paying jobs.

Laura Shawver, PhD, CEO, Cleave Biosciences

Dr. Shawver discusses why this is an exciting time for the industry, and her experiences as a bench scientist turned CEO and founder of a patient advocacy group.

Tracey Mumford from The Michael J. Fox Foundation for Parkinson’s Research

Tracey Mumford from The Michael J. Fox Foundation discusses Parkinson's disease, the Foundation’s work toward a cure, and partnerships they're currently seeking. The Foundation will be one of the patient advocacy groups attending the 2012 BIO International Convention on June 18-21 in Boston, Mass.  

Bob Coughlin of MassBio Talks Innovation

Bob Coughlin discusses the elements of supportive bioscience industry climates and looks ahead to the 2012 BIO International Convention.